About Zinc finger protein 275
Zinc finger protein 275 (ZNF275) is a protein
from Homo sapiens identified by UniProt accession
Q9NSD4, 429 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Zinc finger protein 275 |
| UniProt accession | Q9NSD4 |
| Gene | ZNF275 |
| Organism | Homo sapiens |
| Length | 429 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.37
- benign neoplasm of adrenal gland · score 0.31
- hemoglobin D disease · score 0.05
- dominant beta-thalassemia · score 0.04
- delta-beta-thalassemia · score 0.04
- hemoglobin E disease · score 0.04
- hemoglobin C-beta-thalassemia syndrome · score 0.04
- Alpha-thalassemia - myelodysplastic syndrome · score 0.04
- alpha-thalassemia-myelodysplastic syndrome · score 0.04
- hemoglobin E-beta-thalassemia syndrome · score 0.04
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9NSD4-F1 | alphafold | PREDICTED | 72.15 | — |
Amino-acid sequence (429 residues)
MMSHPCVSLL GVPVLNPALV PHLAQGQVLL VSDPSPNTDP AKYSESTSAT RHQMKGEDAQ PQEMASTSFP RASGPSPEFR QHGDSDGKRG SPQNLPIEHH FACKECGDTF RLKVLLVQHQ RVHSEEKGWE CGDCGKVFRG VAEFNEHRKS HVAAEPQPGP SRALENAAEK REQMEREAKP FECEECGKRF KKNAGLSQHL RVHSREKPFD CEECGRSFKV NTHLFRHQKL HTSEKPFACK ACSRDFLDRQ ELLKHQRMHT GHLPFDCDDC GKSFRGVNGL AEHQRIHSGA KPYGCPHCGK LFRRSSELTK HRRIHTGEKP YACGQCGKAF RQSSSLLEHA RIHSGERPYA CGECGKAFRG PSDLIKHRRI HSGLKPYECD KCGKAFRRSS GLSRHRRIHS GARRCECSQC GRVFKRRSAL QKHQPTHHE
Explore Zinc finger protein 275 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets